DSM Sinochem Pharmaceuticals
DSM Sinochem Pharmaceuticals is a global leader in generic anti-infective molecules formed in 2011 as a 50/50 joint venture between DSM and Sinochem. DSM Sinochem Pharmaceuticals develops, produces and sells intermediates and active pharmaceutical ingredients (APIs) as well as finished dosage. It is at the forefront of technological and process developments for anti-infectives and cholesterol-lowering molecules, using environmentally-friendly production technologies based on biotechnology.
In July 2015 DSM formed ChemicaInvest, a new joint venture with CVC Capital Partners. ChemicaInvest is a global leader in the production and supply of caprolactam and the leading European supplier of acrylonitrile and composite resins. DSM owns 35% of ChemicaInvest which has three business units: